Nifty
Sensex
:
:
23465.60
76992.77
66.70 (0.29%)
181.87 (0.24%)

Pharmaceuticals & Drugs - Global

Rating :
52/99

BSE: 524494 | NSE: IPCALAB

1181.35
14-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1200.00
  •  1213.70
  •  1175.75
  •  1199.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  285975
  •  3413.94
  •  1374.60
  •  691.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 30,004.33
  • 54.82
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 31,094.99
  • 0.34%
  • 4.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 46.30%
  • 0.43%
  • 7.13%
  • FII
  • DII
  • Others
  • 10.51%
  • 33.82%
  • 1.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.58
  • 10.62
  • 4.77

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.41
  • 5.90
  • -9.42

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.13
  • 1.60
  • -25.00

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.95
  • 30.99
  • 34.95

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.21
  • 4.77
  • 4.45

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.76
  • 19.50
  • 20.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
2,033.01
1,511.63
34.49%
2,052.86
1,546.00
32.79%
2,033.96
1,600.95
27.05%
1,587.58
1,585.74
0.12%
Expenses
1,711.11
1,330.59
28.60%
1,721.53
1,330.14
29.42%
1,712.69
1,340.31
27.78%
1,279.96
1,316.51
-2.78%
EBITDA
321.90
181.04
77.81%
331.33
215.86
53.49%
321.27
260.64
23.26%
307.62
269.23
14.26%
EBIDTM
15.83%
11.98%
16.14%
13.96%
15.80%
16.28%
19.38%
16.98%
Other Income
18.92
36.39
-48.01%
22.45
30.89
-27.32%
38.55
36.23
6.40%
44.85
22.11
102.85%
Interest
29.37
18.45
59.19%
33.40
10.84
208.12%
44.12
9.31
373.90%
31.38
6.94
352.16%
Depreciation
98.13
69.54
41.11%
99.50
66.57
49.47%
90.34
63.74
41.73%
69.27
61.71
12.25%
PBT
76.60
129.44
-40.82%
288.89
169.34
70.60%
225.36
223.82
0.69%
251.82
222.69
13.08%
Tax
73.69
48.37
52.35%
66.24
53.73
23.28%
87.92
77.00
14.18%
85.61
74.26
15.28%
PAT
2.91
81.07
-96.41%
222.65
115.61
92.59%
137.44
146.82
-6.39%
166.21
148.43
11.98%
PATM
0.14%
5.36%
10.85%
7.48%
6.76%
9.17%
10.47%
9.36%
EPS
2.35
3.02
-22.19%
7.09
4.25
66.82%
5.72
5.67
0.88%
6.42
5.64
13.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
7,707.41
6,204.26
5,796.74
5,394.94
4,619.03
3,745.69
3,257.76
3,156.19
2,867.11
3,144.40
3,281.77
Net Sales Growth
23.43%
7.03%
7.45%
16.80%
23.32%
14.98%
3.22%
10.08%
-8.82%
-4.19%
 
Cost Of Goods Sold
2,575.75
2,079.50
1,790.78
1,547.98
1,455.41
1,090.34
978.34
939.40
903.04
968.00
963.06
Gross Profit
5,131.66
4,124.76
4,005.96
3,846.96
3,163.62
2,655.35
2,279.42
2,216.79
1,964.07
2,176.40
2,318.71
GP Margin
66.58%
66.48%
69.11%
71.31%
68.49%
70.89%
69.97%
70.24%
68.50%
69.22%
70.65%
Total Expenditure
6,425.29
5,300.99
4,539.12
3,913.71
3,728.56
3,067.42
2,815.78
2,740.77
2,593.42
2,630.33
2,569.79
Power & Fuel Cost
-
283.74
242.12
207.10
201.22
176.50
161.92
151.00
141.67
135.94
127.91
% Of Sales
-
4.57%
4.18%
3.84%
4.36%
4.71%
4.97%
4.78%
4.94%
4.32%
3.90%
Employee Cost
-
1,287.64
1,177.39
1,013.57
921.23
787.40
735.88
695.98
625.58
566.70
497.99
% Of Sales
-
20.75%
20.31%
18.79%
19.94%
21.02%
22.59%
22.05%
21.82%
18.02%
15.17%
Manufacturing Exp.
-
655.66
610.03
524.21
471.80
374.26
366.92
404.52
387.75
439.11
415.69
% Of Sales
-
10.57%
10.52%
9.72%
10.21%
9.99%
11.26%
12.82%
13.52%
13.96%
12.67%
General & Admin Exp.
-
296.10
261.34
242.22
249.90
271.85
268.52
246.68
245.42
246.73
255.40
% Of Sales
-
4.77%
4.51%
4.49%
5.41%
7.26%
8.24%
7.82%
8.56%
7.85%
7.78%
Selling & Distn. Exp.
-
595.47
402.81
324.86
359.15
317.84
277.62
280.74
223.67
245.00
231.18
% Of Sales
-
9.60%
6.95%
6.02%
7.78%
8.49%
8.52%
8.89%
7.80%
7.79%
7.04%
Miscellaneous Exp.
-
102.88
54.65
53.77
69.85
49.23
26.58
22.45
66.29
28.85
231.18
% Of Sales
-
1.66%
0.94%
1.00%
1.51%
1.31%
0.82%
0.71%
2.31%
0.92%
2.39%
EBITDA
1,282.12
903.27
1,257.62
1,481.23
890.47
678.27
441.98
415.42
273.69
514.07
711.98
EBITDA Margin
16.63%
14.56%
21.70%
27.46%
19.28%
18.11%
13.57%
13.16%
9.55%
16.35%
21.69%
Other Income
124.77
151.77
121.72
129.19
86.50
74.66
58.08
54.76
40.77
58.69
51.97
Interest
138.27
48.19
11.20
12.27
19.77
22.24
27.57
26.91
34.56
32.13
30.23
Depreciation
357.24
261.56
232.42
209.17
210.50
182.42
177.73
172.95
163.26
179.55
103.13
PBT
842.67
745.29
1,135.72
1,388.98
746.70
548.27
294.76
270.32
116.64
361.08
630.59
Tax
313.46
253.36
224.77
240.14
135.33
104.24
51.11
67.52
20.44
101.93
152.39
Tax Rate
37.20%
33.99%
19.79%
17.29%
18.12%
19.01%
17.34%
24.98%
17.52%
28.23%
24.17%
PAT
529.21
484.26
905.24
1,147.71
614.13
447.39
243.65
202.80
96.20
259.15
478.20
PAT before Minority Interest
553.64
491.93
910.95
1,148.84
611.37
444.03
243.65
202.80
96.20
259.15
478.20
Minority Interest
24.43
-7.67
-5.71
-1.13
2.76
3.36
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.87%
7.81%
15.62%
21.27%
13.30%
11.94%
7.48%
6.43%
3.36%
8.24%
14.57%
PAT Growth
7.58%
-46.50%
-21.13%
86.88%
37.27%
83.62%
20.14%
110.81%
-62.88%
-45.81%
 
EPS
20.86
19.09
35.68
45.24
24.21
17.63
9.60
7.99
3.79
10.21
18.85

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
5,842.02
5,464.84
4,701.65
3,627.48
3,122.39
2,688.57
2,455.26
2,259.19
2,208.43
1,959.66
Share Capital
25.37
25.37
25.37
25.27
25.27
25.24
25.24
25.24
25.24
25.24
Total Reserves
5,816.65
5,439.47
4,676.28
3,590.27
3,097.12
2,663.01
2,430.02
2,233.95
2,183.19
1,934.42
Non-Current Liabilities
901.72
613.87
189.69
290.29
313.40
419.42
548.32
662.57
699.57
459.45
Secured Loans
651.78
395.18
9.13
88.80
133.94
234.01
347.22
433.63
447.65
292.12
Unsecured Loans
0.00
0.00
0.00
14.17
6.91
0.00
4.52
50.64
55.56
1.88
Long Term Provisions
46.99
42.73
38.56
32.23
25.28
25.88
24.55
20.22
18.03
14.93
Current Liabilities
1,805.82
1,465.88
1,160.54
1,326.42
1,097.50
1,007.57
955.93
969.95
904.36
791.45
Trade Payables
525.06
557.70
664.86
609.85
524.32
423.47
396.54
421.11
306.59
340.99
Other Current Liabilities
488.15
420.52
204.49
304.57
274.74
266.75
316.41
297.50
236.44
250.88
Short Term Borrowings
661.82
367.81
176.61
310.95
209.69
239.04
177.30
184.85
325.35
143.94
Short Term Provisions
130.79
119.85
114.58
101.05
88.75
78.31
65.68
66.49
35.98
55.64
Total Liabilities
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
3,210.56
Net Block
2,751.38
2,402.19
2,072.43
2,058.73
1,940.38
1,952.96
1,983.27
2,014.18
1,800.43
1,353.59
Gross Block
4,364.66
3,749.46
3,201.39
2,985.73
2,632.86
2,464.33
2,318.22
2,176.95
2,546.33
1,932.05
Accumulated Depreciation
1,613.28
1,331.43
1,128.96
927.00
692.48
511.37
334.95
162.77
745.90
578.46
Non Current Assets
3,433.59
3,164.34
2,629.45
2,402.11
2,171.08
2,170.08
2,217.69
2,269.79
2,198.38
1,609.14
Capital Work in Progress
140.43
306.43
234.82
133.28
66.33
73.00
94.64
128.74
267.22
164.90
Non Current Investment
302.66
269.88
111.43
71.31
30.05
17.52
22.24
25.82
16.19
9.00
Long Term Loans & Adv.
229.61
169.63
184.42
124.68
128.36
115.83
103.58
78.44
103.47
71.26
Other Non Current Assets
9.51
16.21
26.35
14.11
5.96
10.77
13.96
22.61
11.07
10.39
Current Assets
5,189.27
4,457.17
3,436.96
2,855.71
2,377.75
1,945.48
1,741.82
1,621.92
1,613.98
1,601.42
Current Investments
323.32
719.31
393.83
238.25
90.38
69.35
113.57
0.00
0.00
0.15
Inventories
1,743.37
1,857.97
1,594.81
1,323.12
1,072.50
880.59
882.22
837.42
926.56
847.58
Sundry Debtors
989.02
910.78
811.75
895.20
681.51
602.27
500.16
445.87
353.00
449.79
Cash & Bank
1,853.24
640.66
365.07
180.92
282.30
150.57
35.85
175.54
124.79
76.01
Other Current Assets
280.32
126.65
234.70
195.92
251.06
242.70
210.02
163.09
209.63
227.89
Short Term Loans & Adv.
155.62
201.80
36.80
22.30
29.85
14.44
15.56
17.31
36.19
53.84
Net Current Assets
3,383.45
2,991.29
2,276.42
1,529.29
1,280.25
937.91
785.89
651.97
709.62
809.97
Total Assets
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
3,210.56

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
805.81
856.07
1,090.13
570.35
501.03
341.13
281.91
708.65
455.29
522.29
PBT
745.29
1,135.72
1,388.98
738.89
546.46
290.53
262.06
116.64
361.08
630.59
Adjustment
235.18
195.11
183.07
247.37
187.36
192.51
174.86
211.11
187.91
139.92
Changes in Working Capital
48.99
-272.72
-236.33
-263.69
-121.97
-84.44
-103.73
410.30
-18.68
-117.72
Cash after chg. in Working capital
1,029.46
1,058.11
1,335.72
722.57
611.85
398.60
333.19
738.05
530.31
652.79
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-223.65
-202.04
-245.59
-152.22
-110.82
-57.47
-51.28
-29.40
-75.02
-130.50
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-725.00
-855.05
-520.69
-509.65
-165.06
-135.40
-148.82
-218.33
-676.40
-369.01
Net Fixed Assets
-344.27
-597.37
-307.20
-284.34
-46.98
-60.09
-105.61
466.60
-716.66
-362.17
Net Investments
281.97
-470.86
-219.12
-326.48
-106.61
-4.05
-114.15
-15.57
-52.96
-6.96
Others
-662.70
213.18
5.63
101.17
-11.47
-71.26
70.94
-669.36
93.22
0.12
Cash from Financing Activity
507.24
426.78
-305.82
-136.54
-183.20
-130.41
-159.13
-461.51
250.54
-136.13
Net Cash Inflow / Outflow
588.05
427.80
263.62
-75.84
152.77
75.32
-26.04
28.81
29.43
17.15
Opening Cash & Equivalents
990.93
559.01
295.39
370.92
218.15
142.83
168.87
140.06
74.25
56.69
Closing Cash & Equivalent
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87
103.68
74.25

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
230.27
215.41
185.32
286.15
247.12
213.02
194.55
179.02
174.99
155.28
ROA
6.06%
13.31%
20.29%
12.47%
10.25%
6.03%
5.17%
2.50%
7.38%
16.19%
ROE
8.70%
17.92%
27.63%
18.15%
15.28%
9.47%
8.60%
4.31%
12.43%
27.22%
ROCE
11.71%
20.46%
30.92%
19.92%
16.53%
9.94%
9.44%
4.82%
13.78%
27.92%
Fixed Asset Turnover
1.54
1.68
1.75
1.65
1.48
1.37
1.43
1.23
1.42
1.89
Receivable days
55.52
53.92
57.48
61.90
62.09
61.27
53.75
50.16
46.12
47.78
Inventory Days
105.25
108.09
98.25
94.05
94.47
97.98
97.70
110.76
101.93
87.49
Payable days
86.04
111.16
136.39
49.85
51.13
50.35
52.23
52.92
39.11
36.45
Cash Conversion Cycle
74.74
50.86
19.34
106.10
105.43
108.90
99.22
108.00
108.95
98.82
Total Debt/Equity
0.25
0.14
0.05
0.13
0.15
0.23
0.29
0.38
0.42
0.31
Interest Cover
16.47
102.40
114.20
38.77
25.65
11.69
11.05
4.38
12.24
21.86

News Update:


  • Ipca Laboratories - Quarterly Results
    29th May 2024, 13:40 PM

    Read More
  • Ipca Laboratories enters into Technology Transfer Agreement with Omexa Formulary
    27th Mar 2024, 15:14 PM

    Ipca will grant to Omexa a non-exclusive right to research, develop, manufacture and market a anti-cancer biosimilar for global market

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.